Martínez-Moragón, Eva
García-Moguel, Ismael
Nuevo, Javier
Resler, Gustavo
Antépara, Ignacio
Arismendi-Núñez, Ebymar
Casas-Maldonado, Francisco
Dávila-González, Ignacio
García-Moguel, Ismael
Velasco-Garrido, Jose Luis
Díaz-Campos, Rocío
Díaz-Donado, Carmen
Gálvez, Beatriz
Izquierdo, Jose Luis
López-Viña, Antolín
Martínez-Moragón, Eva
Navarro-Soriano, Cristina
Palop-Cervera, Marta
de Llano, Luis Pérez
Plaza, Vicente
Racionero-Casero, Miguel Ángel
Rial-Prado, Manuel
Rodríguez-Hernández, Marina Carmen
Rodríguez-Nieto, Maria Jesús
Zabaleta, Miguel
,
Funding for this research was provided by:
AstraZeneca
Article History
Received: 28 June 2021
Accepted: 8 December 2021
First Online: 18 December 2021
Declarations
:
: This study was approved by the AEMPS and by the ethics committee of the Hospital Universitario 12 de Octubre of Madrid. Written informed consent was obtained from all participants.
: Not applicable.
: EM-M received honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events from ALK, AstraZeneca, GlaxoSmithKline, Novartis, Pfizer, Sanofi, and TEVA; has received equipment, materials, or other services from GlaxoSmithKline; and has served as a paid expert and was a member of advisory boards for AstraZeneca, Bial, GlaxoSmithKline, Novartis, Sanofi, and TEVA. IG-M received honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events from Allergy Therapeutics, AstraZeneca, Chiesi, GlaxoSmithKline, Leti, Orionpharma, Sanofi, and Stallergenes; has received equipment, materials, or other services from GlaxoSmithKline; and has served as a paid expert and was a member of advisory boards for AstraZeneca, GlaxoSmithKline, and Sanofi. JN and GR are employees of AstraZeneca.